A real‐world study on the prevalence and risk factors of medication related osteonecrosis of the jaw in cancer patients with bone metastases treated with Denosumab

Abstract Aim Assessing the incidence of Medication Related Osteonecrosis of the Jaw (MRONJ) in cancer patients with bone metastases receiving Denosumab (Dmab) and identifying potential risk factors. Methods A retrospective observational study on consecutive cancer patients with bone metastases, who...

Full description

Bibliographic Details
Published in:Cancer Medicine
Main Authors: Paola Bracchi, Ernesto Zecca, Cinzia Brunelli, Rosalba Miceli, Gabriele Tinè, Massimo Maniezzo, Silvia Lo Dico, Mariangela Caputo, Morena Shkodra, Augusto T. Caraceni
Format: Article
Language:English
Published: Wiley 2023-09-01
Subjects:
bone metastasis
cancer
Denosumab
osteonecrosis of the jaw
risk factors
Online Access:https://doi.org/10.1002/cam4.6429

Internet

https://doi.org/10.1002/cam4.6429

Similar Items